OTC Laxative Recall Expanded; Vi-Jon Investigating 3 Reports of Adverse Events
Immunocompromised individuals may be at an increased risk for invasive infections if a contaminated product is consumed.
Constipation And Bowel Cleansers
OTC Laxative Recalled Due to Microbial Contamination
At this time, there have been no reports of adverse events related to this recall.
Elobixibat Improves Constipation in Chronic Kidney Disease
Improvement also seen in lipid metabolism, with increase in LDL cholesterol and decrease in HDL cholesterol
Microbial Contamination Prompts Recall of Senna Syrup
The recalled lot of Senna Syrup 8.8mg/5mL; NDC # 50268-731-24; Lot AM1115S; Expiration Date 01/2023, was distributed to the wholesaler, AvKare.
New-Onset SVT Following Colonoscopy Bowel Prep Explored in Case Series
A significant percentage of affected patients were observed to have dilated atria and left ventricular hypertrophy.
Study Suggests Limited Efficacy of OTC Meds for Chronic Idiopathic Constipation
Results showed that the majority of patients expressed dissatisfaction with the effect of the OTC agent on constipation and CIC-specific abdominal symptoms.
Sutab Tablets Now Available for Colonoscopy Prep
The product is administered as a split-dose regimen consisting of 2 doses.
Generic Version of Amitiza Now Available
The Company has begun shipping both the 8mcg and 24mcg capsules; the capsules are supplied in 60-count bottles.
FDA Approves Sulfate-Based Tablet Prep for Colonoscopy
Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.
Pizensy Approved for Chronic Idiopathic Constipation
The FDA has approved Pizensy (lactitol; Sebela) for oral solution, an osmotic laxative, for the treatment of chronic idiopathic constipation (CIC) in adult patients.
